What is the share price of CCME Global Ltd (CCME) today?
The share price of CCME as on 12th June 2026 is ₹86.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on CCME Global Ltd (CCME) share?
The past returns of CCME Global Ltd (CCME) share are- Past 1 week: -14.21%
- Past 1 month: -26.41%
- Past 3 months: -2.86%
- Past 6 months: -0.11%
- Past 1 year: 326.72%
- Past 3 years: 747.05%
- Past 5 years: 1113.81%
What are the peers or stocks similar to CCME Global Ltd (CCME)?
The peers or stocks similar to CCME Global Ltd (CCME) include:What is the market cap of CCME Global Ltd (CCME) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of CCME Global Ltd (CCME) is ₹117.72 Cr as of 12th June 2026.What is the 52 week high and low of CCME Global Ltd (CCME) share?
The 52-week high of CCME Global Ltd (CCME) is ₹184.90 and the 52-week low is ₹21.22.What is the PE and PB ratio of CCME Global Ltd (CCME) stock?
The P/E (price-to-earnings) ratio of CCME Global Ltd (CCME) is -165.80. The P/B (price-to-book) ratio is 13.80.Which sector does CCME Global Ltd (CCME) belong to?
CCME Global Ltd (CCME) belongs to the Health Care sector & Biotechnology sub-sector.How to buy CCME Global Ltd (CCME) shares?
You can directly buy CCME Global Ltd (CCME) shares on Tickertape. Simply sign up, connect your demat account and place your order.
CCME Global Ltd
CCME Share Price
BSE₹86.054.97% (-4.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
CCME Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
CCME Performance & Key Metrics
CCME Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -165.80 | 13.80 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 41.70 | 6.09 | 0.56% |
CCME Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CCME Company Profile
Genesis IBRC India Ltd is a biotechnology company focused on developing and marketing microbial and antimicrobial products for aquaculture, agriculture, poultry, and animal husbandry sectors.
BIOCON
PE Ratio
174.70
174.70
1Y Return
17.35%
17.35%
Buy Reco %
73.33
73.33
ANTHEM
PE Ratio
74.23
74.23
1Y Return
6.80%
6.80%
Buy Reco %
100.00
100.00
ACUTAAS
PE Ratio
71.89
71.89
1Y Return
183.09%
183.09%
Buy Reco %
88.89
88.89
SAILIFE
PE Ratio
71.81
71.81
1Y Return
53.43%
53.43%
Buy Reco %
100.00
100.00
ONESOURCE
PE Ratio
-256.50
-256.50
1Y Return
19.50%
19.50%
Buy Reco %
100.00
100.00
CCME Forecast
CCME Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
CCME
CCME
Income
Balance Sheet
Cash Flow
Quarterly Normal View
CCME Income Statement
CCME Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 3.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | ||||||||||
Operating & Other expenses | 0.02 | 3.69 | 0.10 | 0.02 | 0.03 | 0.02 | 0.12 | 0.06 | 0.03 | 0.54 | ||||||||||
EBITDA | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | -0.50 | ||||||||||
| EPS | -0.02 | -2.84 | -0.07 | 2.81 | -0.02 | -0.02 | -0.09 | -0.05 | -0.02 | -0.37 |
CCME Company Updates
CCME Stock Peers
CCME Past Performance & Peer Comparison
CCME Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareBiotechnology
Compare valuation on Screener
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| CCME Global Ltd | -165.80 | 13.80 | — |
| Biocon Ltd | 174.70 | 2.43 | 0.09% |
| Anthem Biosciences Ltd | 74.23 | 18.23 | 0.25% |
| Acutaas Chemicals Ltd | 71.89 | 19.40 | 0.16% |
CCME Stock Price Comparison
Compare CCME with any stock or ETFCompare CCME with any stock or ETF
CCME
CCME Holdings
CCME Shareholdings
CCME Promoter Holdings Trend
CCME Promoter Holdings Trend
CCME Institutional Holdings Trend
CCME Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 2.61%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
CCME Shareholding Pattern
CCME Shareholding Pattern
CCME Shareholding History
CCME Shareholding History
Foreign Institutions
smallcases containing CCME stock
smallcases containing CCME stock
Looks like this stock is not in any smallcase yet.
CCME Events
CCME Events
CCME Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CCME has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CCME Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CCME has not given any dividends in last 5 years
CCME Dividends
CCME Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCCME Stock News & Opinions
CCME Stock News & Opinions
Articles & Videos
Earnings
Earnings
CCME Global reports standalone net loss of Rs 0.50 crore in the March 2026 quarterNet Loss of CCME Global reported to Rs 0.50 crore in the quarter ended March 2026 as against net loss of Rs 0.02 crore during the previous quarter ended March 2025. Sales reported to Rs 0.04 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025. For the full year,net loss reported to Rs 0.71 crore in the year ended March 2026 as against net profit of Rs 3.50 crore during the previous year ended March 2025. Sales declined 98.91% to Rs 0.04 crore in the year ended March 2026 as against Rs 3.67 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales0.040 0 0.043.67 -99 OPM %-1250.000 --1775.0095.37 - PBDT-0.50-0.02 -2400 -0.713.50 PL PBT-0.50-0.02 -2400 -0.713.50 PL NP-0.50-0.02 -2400 -0.713.50 PL Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Corporate
CCME Global to hold board meetingCCME Global will hold a meeting of the Board of Directors of the Company on 29 May 2026.
2 weeks agoCapital Market - Live
Earnings
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.03 crore in the December 2025 quarterNet Loss of Genesis IBRC India reported to Rs 0.03 crore in the quarter ended December 2025 as against net loss of Rs 0.03 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Genesis IBRC India to announce Quarterly ResultGenesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Genesis IBRC India to declare Quarterly ResultsGenesis IBRC India will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.06 crore in the September 2025 quarterNet loss of Genesis IBRC India reported to Rs 0.06 crore in the quarter ended September 2025 as against net profit of Rs 3.65 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 as against Rs 3.67 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales03.67 -100 OPM %099.46 - PBDT-0.063.65 PL PBT-0.063.65 PL NP-0.063.65 PL Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Corporate
Genesis IBRC India to table resultsGenesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Genesis IBRC India to convene AGMGenesis IBRC India announced that the 33th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.12 crore in the June 2025 quarterNet Loss of Genesis IBRC India reported to Rs 0.12 crore in the quarter ended June 2025 as against net loss of Rs 0.10 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Corporate
Genesis IBRC India to convene board meetingGenesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Pledged promoter holdings is insignificant